CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 07:54 PM EDT
CytomX Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 47.6M | 38.05M | 40.58M | 43.25M | 36.19M | 17.17M | 26.02M | 57.54M | 56.36M | 193.65M | 95.04M | 129.29M | 163.49M | 205.53M | 236.28M | 256.15M | 329.67M |
Short-Term Investments | 32.28M | 62.57M | 77.01M | 93.94M | 114.1M | 157.34M | 168.09M | 123.32M | 148.15M | n/a | 99.25M | 98.88M | 99.04M | 99.7M | 5K | 10.03M | 64.13M |
Long-Term Investments | n/a | n/a | n/a | 917K | 917K | 917K | 917K | 917K | 917K | 917K | 917K | 917K | 917K | 917K | 99.97M | 99.91M | 917K |
Other Long-Term Assets | 1.09M | 1.09M | 1.1M | 76K | 80K | 83K | 1M | 1.01M | 944K | -3.57M | 1.81M | 1.81M | 902K | -3.71M | 1.82M | 1.82M | 2.25M |
Receivables | 1.96M | 3.1M | 3.35M | 2.77M | 13.18M | 3.43M | 2.42M | 1.9M | 1.09M | 35.99M | 1.71M | 1.01M | 1.02M | 790K | 887K | 931K | 756K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.79M | 3.58M | 3.24M | 3.12M | 3.79M | 5M | 4.67M | 5.04M | 6.68M | 7.47M | 4.28M | 3.59M | 4.9M | 4.29M | 3.82M | n/a | 5.46M |
Total Current Assets | 86.63M | 107.31M | 124.18M | 143.08M | 167.25M | 182.94M | 201.2M | 187.8M | 212.28M | 237.1M | 200.28M | 232.77M | 268.44M | 310.3M | 241M | 271M | 400.01M |
Property-Plant & Equipment | 9.28M | 10.6M | 12.13M | 13.54M | 14.8M | 16.18M | 17.24M | 18.63M | 19.62M | 21.02M | 22.54M | 23.61M | 24.63M | 25.32M | 26.44M | 27.66M | 28.91M |
Goodwill & Intangibles | 1.5M | 1.53M | 1.57M | 1.6M | 1.64M | 1.68M | 1.72M | 1.75M | 1.79M | 1.82M | 1.86M | 1.9M | 1.93M | 1.97M | 2.01M | 2.04M | 2.08M |
Total Long-Term Assets | 11.87M | 13.23M | 14.8M | 16.14M | 17.44M | 22.21M | 19.96M | 21.38M | 22.35M | 23.79M | 26.21M | 27.32M | 28.38M | 29.11M | 130.24M | 131.44M | 34.15M |
Total Assets | 98.5M | 120.53M | 138.98M | 159.22M | 184.69M | 205.15M | 221.17M | 209.19M | 234.63M | 260.89M | 226.49M | 260.09M | 296.82M | 339.41M | 371.23M | 402.44M | 434.16M |
Account Payables | 276K | 1.09M | 1.42M | 611K | 1.96M | 1.46M | 1.71M | 1.03M | 2.2M | 2.81M | 5.18M | 1.92M | 1.72M | 2.82M | 1.52M | 1.75M | 2.58M |
Deferred Revenue | 33.23M | 67.2M | 96.06M | 123.77M | 123.63M | 132.27M | 124.4M | 120.28M | 126.78M | 121.27M | 61.33M | 65.79M | 70.01M | 69.26M | 73.09M | 72.37M | 76.64M |
Short-Term Debt | n/a | n/a | n/a | 4.86M | n/a | 4.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | 9.76M | n/a | 6.05M | 9.37M | 9.7M | 9.13M | 10.3M | 13.7M | 16.39M | 21.05M | 20.78M | 21.48M | 21.04M | 13.84M | 10.05M | 10.49M |
Total Current Liabilities | 50.2M | 85.77M | 119.23M | 142.86M | 144.54M | 155.91M | 146.79M | 141.38M | 151.26M | 152.61M | 97.84M | 99.44M | 102.77M | 106.32M | 99.77M | 93.38M | 98.05M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 9.38M | 10.6M | 11.75M | n/a | 13.97M | 15.05M | 16.08M | 17.08M | 18.06M | 19.02M | 19.92M | 20.81M |
Other Long-Term Liabilities | 4.18M | 4.12M | 37.61M | 3.99M | 3.94M | -5.49M | -7.84M | -11.53M | n/a | -13.97M | -15.05M | -16.08M | -17.08M | -18.06M | -19.02M | -19.92M | -20.81M |
Total Long-Term Liabilities | 23.25M | 35.22M | 43.2M | 47.59M | 71.83M | 96.69M | 125.61M | 152.84M | 170M | 194.03M | 100.18M | 111.94M | 125.86M | 143.72M | 159.79M | 178.11M | 190.09M |
Total Liabilities | 73.45M | 120.99M | 162.43M | 190.45M | 216.37M | 252.6M | 272.4M | 294.21M | 321.27M | 346.64M | 198.02M | 211.38M | 228.63M | 250.03M | 259.56M | 271.49M | 288.14M |
Total Debt | 8.15M | 9.38M | 10.6M | 11.75M | 12.87M | 13.97M | 15.05M | 16.08M | 17.08M | 18.06M | 19.02M | 19.92M | 20.81M | 21.67M | 22.53M | 23.32M | 24.1M |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
Retained Earnings | -668.05M | -691.58M | -710.46M | -716.19M | -709.66M | -723.45M | -724.28M | -727.28M | -726.19M | -722.88M | -605.09M | -581.79M | -557.61M | -533.72M | -507.5M | -484.91M | -465.67M |
Comprehensive Income | -1K | 27K | 40K | -4K | -10K | 95K | -63K | 35K | 26K | 10K | -795K | -1.16M | -919K | -242K | 52K | 15K | -43K |
Shareholders Equity | 25.05M | -456K | -23.45M | -31.23M | -31.68M | -47.45M | -51.24M | -85.03M | -86.64M | -85.75M | 28.47M | 48.71M | 68.19M | 89.38M | 111.67M | 130.95M | 146.02M |
Total Investments | 32.28M | 62.57M | 77.01M | 94.85M | 115.02M | 158.25M | 168.09M | 123.32M | 148.15M | 917K | 99.25M | 98.88M | 99.04M | 99.7M | 99.97M | 109.94M | 64.13M |